Methods of increasing the cytotoxicity of chemotherapeutic agents with multisubstrate inhibitors of histone, protein-Lys, polyamine acetylation, and polyamine metabolism
申请人:Vanderbilt University
公开号:US10617656B2
公开(公告)日:2020-04-14
A method of treating cancer in a subject in need thereof, comprising administering to the subject a first amount of a compound of the HAT inhibitor of the following formula:
wherein R is chosen from coenzyme A, (CH2)2NHCO(CH2)2NHCOR2; (CH2)2NHCOR3; (CH2)2NHCO(CH2)2NHCOR4; R1 is H, NH2, NH, N, and R1 can optionally cyclize with at least one other X2 to form a C3-8 membered ring containing C, O, S, or N; R2 is chosen from alkyl, cycloalkyl, aryl, heteroaryl; R3 is chosen from an alkyl, cycloalkyl, aryl, heteroaryl; R4 is chosen from CH(OH)C(CH3)2CH2)OCOR2; X1 is chosen from H or can cyclize with one other X2 or R1 to form a C3-8 membered ring containing C, O, S, or N; and X2 is chosen from C, N, NH, and can optionally cyclize with at least one other X2 or R1 to form a C3-8 membered ring containing C, O, S, or N; or a pharmaceutically acceptable salt or hydrate thereof, thereby treating the cancer.
一种治疗有需要的受试者癌症的方法,包括向受试者施用第一种量的下式 HAT
抑制剂化合物:
其中 R 选自
辅酶 A、(
CH2)2NHCO( )2NHCOR2;( )2NHCOR3;( )2NHCO( )2NHCOR4;R1 为 H、NH2、NH、N,且 R1 可任选与至少另一个 X2 环化形成含 C、O、S 或 N 的 C3-8 分子环;R2 选自烷基、环烷基、芳基、杂芳基;R3 选自烷基、环烷基、芳基、杂芳基;R4 选自 CH(OH)C(
CH3)2 )OCOR2;X1 选自 H,或可与另一个 X2 或 R1 环化形成含 C、O、S 或 N 的 C3-8 分子环;X2 选自 C、N、NH,并可任选与至少另一个 X2 或 R1 环化形成含 C、O、S 或 N 的 C3-8 分子环;或其药学上可接受的盐或
水合物,从而治疗癌症。